Abstract
In research-intensive high-technology industries, it is often impossible for startup managers to build up internally all resources necessary for a successful company development. Hence, startups enter into strategic alliances with other companies or into mergers and acquisitions (M&As). Whereas alliances of startups are well studied in the literature, work on M&As mostly focuses on large corporations, but neglects deals between small entrepreneurial firms. In this exploratory study, we analyse six M&A cases of German biotechnology startups. We illustrate specific motives, benefits and problems associated with these deals. Our findings have implications for start-up managers and the future development of the German biotech industry.
Originalsprache | Englisch |
---|---|
Seiten (von - bis) | 1-19 |
Seitenumfang | 19 |
Fachzeitschrift | International Journal of Biotechnology |
Jahrgang | 9 |
Ausgabenummer | 1 |
DOIs | |
Publikationsstatus | Veröffentlicht - 2007 |
Extern publiziert | Ja |